Therefore, not only do platelets protect MM cells from NK cell-mediated cytotoxicity, but they may also be involved in cell adhesion-mediated drug resistance through the PSGL1/P-selectin axis, making them a valuable target for novel MM therapies. Here, SELP is linked to Miyoshi myopathy.